Anthem Biosciences Limited (IN:ANTHEM)

:ANTHEM

ANTHEM

Anthem Biosciences Limited

RESEARCH TOOLSreports

Want to see IN:ANTHEM full AI Analyst Report?

Anthem Biosciences Limited (ANTHEM) Price & Analysis

5 Followers

ANTHEM Stock Chart & Stats

₹757.35

Market closed

₹757.35

Day’s Range― - ―

52-Week Range₹579.45 - ₹873.25

Previous CloseN/A

VolumeN/A

Average Volume (3M)144.08K

Market Cap

₹428.08B

Enterprise Value₹424.66B

Total Cash (Recent Filing)₹11.00B

Total Debt (Recent Filing)₹1.10B

Price to Earnings (P/E)72.1

Beta0.97

Next Earnings

Aug 19, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)4.57

Shares Outstanding563,195,100

10 Day Avg. Volume43,734

30 Day Avg. Volume144,079

Financial Highlights & Ratios

PEG Ratio1.99

Price to Book (P/B)12.10

Price to Sales (P/S)17.33

P/FCF Ratio52.17

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹802.50

Price Target Upside5.96% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)12.56

Revenue Forecast (FY)₹25.66B

Bulls Say, Bears Say

Bulls Say

Accelerated Revenue GrowthA ~106% YoY revenue jump signals substantial contract wins or scaling of CDMO/CRD engagements, indicating stronger commercial traction and broader market acceptance. If sustained, this growth can improve operating leverage and create durable scale advantages over 2–6 months.

Improved Cash GenerationA sharp increase in operating and free cash flow enhances internal funding for capex and working capital, reduces reliance on external financing, and supports reinvestment in capacity or R&D. Strong cash conversion underpins long-term financial flexibility and resilience.

Low Leverage / Strong Balance SheetLow net debt and rising equity provide a conservative capital structure that supports investment, M&A optionality, and downside protection. A strong balance sheet makes funding growth or weathering lumpy project cash flows easier without stressing liquidity.

Bears Say

Sustainability Risk Of FY2026 SurgeAn outsized single-year revenue and cash-flow step-up can reflect concentrated, timing-driven contract milestones or one-offs. Without multi-year trends, forecasting long-term earnings and capex needs is uncertain, raising the risk that margins and cash conversion may revert.

Limited Margin DetailAbsence of granular margin and segment mix data obscures whether growth came from higher-margin discovery services or lower-margin manufacturing volumes. That opacity hinders assessment of recurring profitability and the durability of operating margins over the medium term.

Project-based Revenue LumpyHeavy reliance on contract-based CRD/CDMO work creates revenue lumpiness tied to project timing and capacity. Client concentration or lower utilization can quickly dent cash flow and utilization-driven margins, making multi-quarter visibility and predictability challenging.

Anthem Biosciences Limited News

Anthem Biosciences Posts Earnings Call Audio for Q3 and Nine-Month FY2025 Results

Anthem Biosciences Limited ( ($IN:ANTHEM) ) just unveiled an announcement. Anthem Biosciences Limited has informed the stock exchanges...

4M ago

Anthem Biosciences Issues Revised Details for Q3 FY26 Earnings Call

An announcement from Anthem Biosciences Limited ( ($IN:ANTHEM) ) is now available. Anthem Biosciences Limited has issued a...

4M ago

Anthem Biosciences Schedules Investor Meeting in Bangalore

Anthem Biosciences Limited ( ($IN:ANTHEM) ) has shared an update. Anthem Biosciences Limited announced a scheduled meeting with...

6M ago

Anthem Biosciences Releases Q3 2025 Earnings Presentation

Anthem Biosciences Limited ( ($IN:ANTHEM) ) has issued an update. Anthem Biosciences Limited has released its earnings call...

7M ago

Anthem Biosciences Reports Strong Financial Performance for Q2 and H1 FY26

The latest update is out from Anthem Biosciences Limited ( ($IN:ANTHEM) ). Anthem Biosciences Limited announced its unaudited...

7M ago

Anthem Biosciences Schedules Earnings Call to Discuss Q2 & H1 FY2026 Results

Anthem Biosciences Limited ( ($IN:ANTHEM) ) has issued an update. Anthem Biosciences Limited has announced an upcoming Earnings...

7M ago

ANTHEM FAQ

What was Anthem Biosciences Limited’s price range in the past 12 months?

Anthem Biosciences Limited lowest stock price was ₹579.45 and its highest was ₹873.25 in the past 12 months.

What is Anthem Biosciences Limited’s market cap?

Anthem Biosciences Limited’s market cap is ₹428.08B.

When is Anthem Biosciences Limited’s upcoming earnings report date?

Anthem Biosciences Limited’s upcoming earnings report date is Aug 19, 2026 which is in 79 days.

How were Anthem Biosciences Limited’s earnings last quarter?

Anthem Biosciences Limited released its earnings results on May 19, 2026. The company reported ₹3.38 earnings per share for the quarter, beating the consensus estimate of ₹2.833 by ₹0.547.

Is Anthem Biosciences Limited overvalued?

According to Wall Street analysts Anthem Biosciences Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Anthem Biosciences Limited pay dividends?

Anthem Biosciences Limited does not currently pay dividends.

What is Anthem Biosciences Limited’s EPS estimate?

Anthem Biosciences Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Anthem Biosciences Limited have?

Anthem Biosciences Limited has 563,195,100 shares outstanding.

What happened to Anthem Biosciences Limited’s price movement after its last earnings report?

Anthem Biosciences Limited reported an EPS of ₹3.38 in its last earnings report, beating expectations of ₹2.833. Following the earnings report the stock price went down -0.361%.

Which hedge fund is a major shareholder of Anthem Biosciences Limited?

Currently, no hedge funds are holding shares in IN:ANTHEM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Anthem Biosciences Limited

Anthem Biosciences Limited operates as technology-focused contract research, development, and manufacturing organization. It operates through two segments: Contract Research, Development & Manufacturing (CRDMO) services; and Speciality Ingredients. The company offers end-to-end services across the new chemical entity and new biological entity lifecycles, including target identification and the concept stage; preclinical development; and manufacturing development batches of molecules used for clinical Phase I, II, and III trials up to commercial manufacturing of RNA-based therapies, antibody-drug conjugates, peptides and oligonucleotides, lipids, biologics and biotherapeutics, fermentation, biosynthesis and biotransformation, and flow chemistry. It also manufactures and sells complex specialized fermentation-based active pharmaceutical ingredients (APIs), including serratiopeptidase protease and vitamin K2; microbial and mammalian biosimilars; probiotics, such as bacillus species, lactobacillus species, bifidobacterium species, streptococcus species and saccharomyces boulardii; enzymes; peptides, including semaglutide, plecanatide, linaclotide, liraglutide, and cilengitide; nutritional actives, vitamin analogues, and APIs. The company was incorporated in 2006 and is based in Bengaluru, India.

Anthem Biosciences Limited (ANTHEM) Earnings & Revenues

Historic Earnings Reports

ANTHEM Stock 12 Month Forecast

Average Price Target

₹802.50

▲(5.96% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"591":"₹591","656":"₹656","721":"₹721","786":"₹786","851":"₹851"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":850,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹850.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":802.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹802.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":755,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹755.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[591,656,721,786,851],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,759.75,766.6923076923077,773.6346153846154,780.5769230769231,787.5192307692307,794.4615384615385,801.4038461538462,808.3461538461538,815.2884615384615,822.2307692307693,829.1730769230769,836.1153846153846,843.0576923076923,{"y":850,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,759.75,763.0384615384615,766.3269230769231,769.6153846153846,772.9038461538462,776.1923076923077,779.4807692307693,782.7692307692307,786.0576923076923,789.3461538461538,792.6346153846154,795.9230769230769,799.2115384615385,{"y":802.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,759.75,759.3846153846154,759.0192307692307,758.6538461538462,758.2884615384615,757.9230769230769,757.5576923076923,757.1923076923077,756.8269230769231,756.4615384615385,756.0961538461538,755.7307692307693,755.3653846153846,{"y":755,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":733.1,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":733.1,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":733.1,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":737.95,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":814.85,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":771.7,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":710.4,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":659.65,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":639,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":592.65,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":686.65,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":667.05,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":759.75,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >